Literature DB >> 16721586

Serum cystatin C and left ventricular diastolic dysfunction in children with chronic kidney disease.

Mark Mitsnefes1, Thomas Kimbal, Janis Kartal, Thelma Kathman, Jaya Mishra, Prasad Devarajan.   

Abstract

Previous studies indicate that serum cystatin C predicts incident heart failure in older adults. Children with chronic kidney disease (CKD) develop left ventricular (LV) diastolic dysfunction, often the initial abnormality of cardiac function. We hypothesized that cystatin C might predict LV diastolic dysfunction in children with CKD. Fifty-seven subjects, aged 6-21 years, with stage 2-4 CKD underwent echocardiography. Diastole was assessed from transmitral Doppler [maximum early (E wave) and late (A wave) diastolic flow velocities (E/A ratio)] and from tissue Doppler [septal mitral annular peak velocities (E')]. LV filling pressures were determined, using a ratio of E/E'. Fourteen (25%) patients had low E' and 15 (26%) had high E/E'. Children with abnormal E' or E/E' had significantly higher cystatin C levels than children with normal indices (P<0.05). Neither serum creatinine nor measured glomerular filtration rate (GFR) significantly correlated with E' or E/E'. Stepwise multiple regression analysis showed that cystatin C (beta=-0.825, P=0.023) and left ventricular mass (LVM) index (beta=0.099, P=0.006) independently predicted E'; LVM index independently predicted E/E' (beta=0.0173, P=0.01). We conclude that, in contrast to measured GFR or serum creatinine level, elevated serum cystatin C might be associated with diastolic dysfunction in children with CKD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721586     DOI: 10.1007/s00467-006-0132-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Cystatin C: our experience.

Authors:  Snezana Pavićević; Amira Peco-Antić
Journal:  Pediatr Nephrol       Date:  2005-06       Impact factor: 3.714

4.  Left ventricular abnormalities in children, adolescents and young adults with renal disease.

Authors:  L M Johnstone; C L Jones; L E Grigg; J L Wilkinson; R G Walker; H R Powell
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

5.  Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.

Authors:  Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

6.  Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.

Authors:  Wolfgang Koenig; Dorothee Twardella; Hermann Brenner; Dietrich Rothenbacher
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

7.  Impaired left ventricular diastolic function in children with chronic renal failure.

Authors:  Mark M Mitsnefes; Thomas R Kimball; William L Border; Sandra A Witt; Betty J Glascock; Philip R Khoury; Stephen R Daniels
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

8.  Predictors of heart failure among women with coronary disease.

Authors:  Kirsten Bibbins-Domingo; Feng Lin; Eric Vittinghoff; Elizabeth Barrett-Connor; Stephen B Hulley; Deborah Grady; Michael G Shlipak
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

9.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

10.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

View more
  7 in total

1.  Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.

Authors:  Joachim H Ix; Michael G Shlipak; Glenn M Chertow; Sadia Ali; Nelson B Schiller; Mary A Whooley
Journal:  J Card Fail       Date:  2006-10       Impact factor: 5.712

2.  Cystatin C and Cardiac Measures in Children and Adolescents With CKD.

Authors:  Tammy M Brady; Kelly Townsend; Michael F Schneider; Christopher Cox; Thomas Kimball; Peace Madueme; Bradley Warady; Susan Furth; Mark Mitsnefes
Journal:  Am J Kidney Dis       Date:  2016-11-14       Impact factor: 8.860

Review 3.  Cystatin C, kidney function and cardiovascular disease.

Authors:  Arend Bökenkamp; Stefan Herget-Rosenthal; Regina Bökenkamp
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

4.  The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score.

Authors:  Sheena Sharma; Michelle R Denburg; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2017-05-08       Impact factor: 3.714

5.  Bias and precision of estimated glomerular filtration rate in children.

Authors:  Norbert Gretz; Daniel Schock; Maliha Sadick; Johannes Pill
Journal:  Pediatr Nephrol       Date:  2006-11-23       Impact factor: 3.714

6.  Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth.

Authors:  Ravi Retnakaran; Philip W Connelly; Stewart B Harris; Bernard Zinman; Anthony J G Hanley
Journal:  Pediatr Nephrol       Date:  2007-03-30       Impact factor: 3.714

7.  Cystatin C and risk of heart failure in the Physicians' Health Study (PHS).

Authors:  Luc Djoussé; Tobias Kurth; J Michael Gaziano
Journal:  Am Heart J       Date:  2007-10-17       Impact factor: 4.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.